WallStSmart
TLSA

Tiziana Life Sciences Ltd

NASDAQ: TLSA · HEALTHCARE · BIOTECHNOLOGY

$1.28
+1.59% today

Updated 2026-04-30

Market cap
$159.06M
P/E ratio
P/S ratio
EPS (TTM)
$-0.12
Dividend yield
52W range
$1 – $3
Volume
0.1M

Tiziana Life Sciences Ltd (TLSA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Operating cash flow$-1.18M$-1.96M$-2.15M$-959801.00$-535421.00$-407862.00$-881912.00$-227890.00$-97129.00$-2.31M$-5.70M$-5.62M$-5.68M$-3.63M$-5.29M$-8.76M$-16.13M$-15.99M$-12.42M$-1.22M
Capital expenditures$11401.00$12191.00$711.00$111000.00$3.00$66986.00$0.00$0.00$0.00$205900.00$1.69M$38463.00$968.00$1.00$2983.00$1887.00$16307.00$0.00$0.00$15181.00
Depreciation
Stock-based comp$13714.00$174516.00$-140583.00$133523.00$33936.00$34628.00$510521.00$4.76M$1.25M$732462.00$801949.00$1.30M$5.10M$5.17M$-1.41M$1.73M$1.43M
Free cash flow$-1.20M$-1.98M$-2.15M$-1.07M$-535424.00$-474848.00$-881912.00$-227890.00$-97129.00$-2.52M$-7.39M$-5.65M$-5.68M$-3.63M$-5.29M$-8.76M$-16.15M$-15.99M$-12.42M$-1.23M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00